Equities

23andMe Holding Co.

ME:NAQ

23andMe Holding Co.

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.23
  • Today's Change0.08 / 2.54%
  • Shares traded1.00
  • 1 Year change-81.29%
  • Beta1.1720
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(667)(312)(217)
Depreciation/depletion233224
Non-Cash items47312625
Cash taxes paid, supplemental------
Cash interest paid, supplemental------
Changes in working capital(0.55)(16)(0.52)
Total cash from operations(164)(165)(167)
INVESTING
Capital expenditures(9.66)(11)(14)
Other investing and cash flow items, total0.030.01(94)
Total cash from investing(9.63)(11)(108)
FINANCING
Financing cash flow items(0.59)(0.89)(31)
Total cash dividends paid------
Issuance (retirement) of stock, net4.1711577
Issuance (retirement) of debt, net------
Total cash from financing3.589.78546
NET CHANGE IN CASH
Foreign exchange effects00.39(0.15)
Net change in cash(170)(167)271
Net cash-begin balance/reserved for future use395562291
Net cash-end balance/reserved for future use225395562
SUPPLEMENTAL INCOME
Depreciation, supplemental233224
Cash interest paid, supplemental------
Cash taxes paid, supplemental------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.